|
Volumn 33, Issue 8, 2001, Pages 611-617
|
GB virus C/hepatitis G virus infection in patients investigated for chronic liver disease and in the general population in southern Sweden
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
HEPATITIS ANTIBODY;
HEPATITIS G VIRUS E2 ANTIBODY;
HEPATITIS GB VIRUS C ANTIBODY;
UNCLASSIFIED DRUG;
VIRUS RNA;
ADULT;
ARTICLE;
BILE DUCT;
BLOOD ANALYSIS;
CHRONIC LIVER DISEASE;
CONTROLLED STUDY;
DEGENERATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EXPOSURE;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS G VIRUS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LIVER BIOPSY;
MAJOR CLINICAL STUDY;
MALE;
PATHOLOGIST;
PATIENT REFERRAL;
POLYMERASE CHAIN REACTION;
POPULATION;
PREVALENCE;
SWEDEN;
VIREMIA;
VIRUS INFECTION;
BIOLOGICAL MARKERS;
BIOPSY;
CASE-CONTROL STUDIES;
CHRONIC DISEASE;
FEMALE;
FLAVIVIRIDAE INFECTIONS;
GB VIRUS C;
HEPATITIS ANTIBODIES;
HEPATITIS, VIRAL, HUMAN;
HUMANS;
INCIDENCE;
LIVER;
LIVER DISEASES;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SWEDEN;
|
EID: 0034893086
PISSN: 00365548
EISSN: None
Source Type: Journal
DOI: 10.1080/00365540110026755 Document Type: Article |
Times cited : (6)
|
References (32)
|